Statins × kidney outcomes

TrialAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2009

Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS).

Helen M Colhoun et al.PubMed ↗Publisher ↗

What the trial testedas reported · 2,838 people · 2009

Range includes no effect

No clear effect on kidney outcomes

1.5×0.7× to 3×

Bigger than 7 in 10 on the map

As reported

HR 1.49, 95% CI 0.73–3.04

Range includes no effect

No clear effect on kidney outcomes

1.2×0.6× to 2.5×

Bigger than 4 in 10 on the map

As reported

HR 1.19, 95% CI 0.57–2.49

Not counted

Raised kidney outcomes

+37.0percentage points+17.0 to +52.0

As reported

difference 37 %, 95% CI 17.0–52.0

Three numbers in the abstract

the abstract, start to end

incidence of albuminuria (hazard ratio, 1.49; 95% CI, 0.73 to 3.04; P = 0.3) or regression to normoalbuminuria (hazard ratio, 1.19; 95% CI, 0.57 to 2.49; P =

This treatment effect was similar to the 37% (95% CI, 17 to 52; P < 0.001)

← favours treatmentfavours comparator →
could be chance
Kidney outcomes
HR 1.490.73–3.04
Kidney outcomes
HR 1.190.57–2.49
Kidney outcomes
3717.0–52.0
StatinsKidney outcomes

Statins × kidney outcomeshelps?mixed

unlikelylikely
0.000.00 without it
← favours treatmentfavours comparator →
this papermore certainless certain
1 / 6

89 papers cite itlatest 60 shown

2009
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 19540640